Detection of ALK gene rearrangement in non-small cell lung cancer: a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization with correlation of ALK protein expression.
about
Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for MolecularCrizotinib: a breakthrough for targeted therapies in lung cancerPlatform comparison for evaluation of ALK protein immunohistochemical expression, genomic copy number and hotspot mutation status in neuroblastomasMolecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for MolecularBiomarker testing for breast, lung, and gastroesophageal cancers at NCI designated cancer centers.Chromogenic in situ hybridization is a reliable assay for detection of ALK rearrangements in adenocarcinomas of the lung.Tumour heterogeneity in the clinic.Chromogenic in situ hybridisation (CISH) is a powerful method to detect ALK-positive non-small cell lung carcinomas.Fluorescence in situ hybridization and immunohistochemistry as diagnostic methods for ALK positive non-small cell lung cancer patientsNew strategies for treatment of ALK-rearranged non-small cell lung cancers.ALK-rearranged lung cancer in Chinese: a comprehensive assessment of clinicopathology, IHC, FISH and RT-PCR.A comprehensive comparative analysis of the histomorphological features of ALK-rearranged lung adenocarcinoma based on driver oncogene mutations: frequent expression of epithelial-mesenchymal transition markers than other genotypeEML4-ALK fusion gene in Korean non-small cell lung cancerThe role of molecular pathology in non-small-cell lung carcinoma-now and in the future.Membranous Insulin-like Growth Factor-1 Receptor (IGF1R) Expression Is Predictive of Poor Prognosis in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Lung AdenocarcinomaAnaplastic lymphoma kinase gene rearrangement in non-small-cell lung cancer in a Brazilian population.Decoding Tumor Phenotypes for ALK, ROS1, and RET Fusions in Lung Adenocarcinoma Using a Radiomics ApproachEML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendationsCrizotinib for the treatment of ALK-rearranged non-small cell lung cancer: a success story to usher in the second decade of molecular targeted therapy in oncologyALK-rearranged pulmonary adenocarcinoma in Thai Patients: From diagnosis to treatment efficacy.ALK-Positive Renal Cell Carcinoma in a Large Series of Consecutively Resected Korean Renal Cell Carcinoma Patients.Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants.The molecular detection and clinical significance of ALK rearrangement in selected advanced non-small cell lung cancer: ALK expression provides insights into ALK targeted therapy.Prognostic significance of stem cell-related marker expression and its correlation with histologic subtypes in lung adenocarcinoma.Diagnostic assays for identification of anaplastic lymphoma kinase-positive non-small cell lung cancer.Guideline Recommendations for Testing of ALK Gene Rearrangement in Lung Cancer: A Proposal of the Korean Cardiopulmonary Pathology Study Group.Colorimetric in situ hybridization identifies MYC gene signal clusters correlating with increased copy number, mRNA, and protein in diffuse large B-cell lymphoma.MicroRNA expression profiles and clinicopathological implications in lung adenocarcinoma according to EGFR, KRAS, and ALK statusAnaplastic lymphoma kinase: a glimmer of hope in lung cancer treatment?Current status of targeted therapy for anaplastic lymphoma kinase-rearranged non-small cell lung cancer.Newly available antibodies with practical applications in surgical pathology.Current clinical application of genomic and proteomic profiling in non-small-cell lung cancer.Prognostic and predictive biomarkers in lung cancer. A review.Preparing for tomorrow: molecular diagnostics and the changing nonsmall cell lung cancer landscape.ALK gene alterations in cancer: biological aspects and therapeutic implications.Targeted inhibition in tumors with ALK dependency.ROS1 gene rearrangement and copy number gain in non-small cell lung cancer.ALK in Non-Small Cell Lung Cancer (NSCLC) Pathobiology, Epidemiology, Detection from Tumor Tissue and Algorithm Diagnosis in a Daily Practice.Custom Gene Capture and Next-Generation Sequencing to Resolve Discordant ALK Status by FISH and IHC in Lung Adenocarcinoma.Detection of EML4-ALK and other ALK fusion genes in lung cancer: a lesson from the leukemia fusion gene analysis and future application.
P2860
Q26828860-61283CE9-4CF6-4A4D-8813-5F46685421D6Q33885657-24993E5A-102D-4526-9319-33E75AB05063Q34134105-50E30264-4B31-4883-9230-CC5D811BF1B3Q34159011-9B356620-E5D3-40FA-AE2A-E0E66CFF17B9Q34248282-187D51E5-65CA-4E86-AFC5-00248A56C973Q34349164-B2C9E97A-663E-43D9-91C9-BEBE8D54BA3DQ34372080-153BA174-12BC-4525-BDDF-3133E5B12F1EQ34389047-04A03FDD-E9F2-4DA4-9A3D-D703E327039FQ34566472-48415AF6-255B-4291-A3D8-7419B8173E97Q34633121-FF683E28-09DC-4D66-B660-C5757F425B2CQ34902031-AB98A2B6-B85B-4736-930C-A754434786FCQ35032336-B5C2F068-58B8-4098-9159-E8694B1BB06CQ35730962-FD7FF2E8-B059-4F3C-B591-9C9694A6499CQ36040599-D10C67C4-D1D1-4902-9DE7-C6FD448A01B3Q36084143-77824FCB-DFBC-4F81-8B9C-16B25B455993Q36104115-3E7F0672-3682-4A31-91AF-2DAFD01439E0Q36195557-72B1A38B-208C-4459-AB16-D30F549B9C4AQ36203525-CF6B637C-3F8D-4A65-A3A9-6355AD15758FQ36405628-B19CA607-099E-48B0-BE7C-F3F5B5C56917Q36866859-BA64B63D-7334-40C7-9781-4D1AA523D49CQ37316727-DCBA5F78-F5BF-4603-BBF9-615E9320F1BBQ37349315-8C4843D0-FCE0-424F-94E6-D36F7D55FE86Q37431563-6A4BAC93-D4AC-4D98-8A43-A0220C21B95CQ37520600-5626E5DC-D9A9-46B2-AFCF-B24058FA5280Q37604076-160F6F10-F7B0-41D2-BAC2-D0893F755C45Q37631021-64AD48C4-C915-4E97-826E-3BA13990A1AAQ37677852-792AC31F-1434-4315-8C05-8CA386D6A683Q37702742-28E3BDA4-5FCC-4F49-AF5E-8266348333ADQ38096472-2B1EE04D-F4A2-4461-B90D-2C93EF87A587Q38148969-8A07D14C-DEEF-45C1-80AD-64D866D10DDDQ38162350-4EEC2EC8-ABAA-431E-BE88-56DD1F3F25EEQ38172914-999242EF-13E5-46DF-B1C3-46DFA4C12EFFQ38178187-4D143305-BA56-4E86-8EE1-B50B5283BEBEQ38199766-8D1E437C-86D9-4C9B-8F34-733EB24E2A8CQ38767006-A4D2A8F1-81C9-4695-924E-01ACEBD6C258Q38956321-A31C1708-5C5C-4C01-A512-9CB30350F177Q39102554-74810AA5-92B0-45FD-8201-AC4C3078561DQ40084048-8B2EA0B7-ED73-420A-86FA-552FCF0B3AFAQ40523842-06517D1B-4494-481D-BCC5-D2B61074BBC4Q43159885-EBC14FD0-DBC3-4980-B6E9-E338F0B4063F
P2860
Detection of ALK gene rearrangement in non-small cell lung cancer: a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization with correlation of ALK protein expression.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Detection of ALK gene rearrang ...... ion of ALK protein expression.
@ast
Detection of ALK gene rearrang ...... ion of ALK protein expression.
@en
type
label
Detection of ALK gene rearrang ...... ion of ALK protein expression.
@ast
Detection of ALK gene rearrang ...... ion of ALK protein expression.
@en
prefLabel
Detection of ALK gene rearrang ...... ion of ALK protein expression.
@ast
Detection of ALK gene rearrang ...... ion of ALK protein expression.
@en
P2093
P1476
Detection of ALK gene rearrang ...... ion of ALK protein expression.
@en
P2093
Choon-Taek Lee
Hiroaki Nitta
Hyojin Kim
Ji-Young Choe
Jin Ho Paik
Jin-Haeng Chung
Sanghoon Jheon
Seol-Bong Yoo
Thomas M Grogan
Wenjun Zhang
P304
P356
10.1097/JTO.0B013E31821CFC73
P577
2011-08-01T00:00:00Z